Xenon Pharmaceuticals (NASDAQ: XENE) reported Q2 EPS of ($0.37), $0.09 better than the analyst estimate of ($0.46).Dr. Simon Pimstone, Xenon’s ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE